Thromboembolism in the obese pregnant woman

Seminars in Perinatology

Volumn 35, Issue 6, 2011, Pages 330-334

  Liston, Fiona ^a   Davies, Gregory A L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Deep vein thrombosis; Obesity; Pregnancy; Pulmonary embolus; Thromboprophylaxis

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TINZAPARIN;

ANTEPARTUM HEMORRHAGE; BLEEDING DISORDER; CESAREAN SECTION; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; OBESITY; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT PLANNING; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; WOUND HEMORRHAGE;

ANTICOAGULANTS; BED REST; CESAREAN SECTION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PUERPERAL DISORDERS; RISK FACTORS; THROMBOEMBOLISM;

EID: 82955180295     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.05.017     Document Type: Review

References (48)

1. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 2003, 52:1-8.
2. Marik P.E., Plante L.A. Venous thromboembolic disease and pregnancy. N Engl J Med 2008, 359:2025-2033.
3. Heit J.A., Kobbervig C.E., James A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study. Ann Intern Med 2005, 143:697-706.
4. James A.H. Pregnancy and thrombotic risk. Crit Care Med 2010, 38:S57-S63.
5. Lindqvist P., Dahlback B., Marsal K. Thrombotic risk during pregnancy: A population study. Obstet Gynecol 1999, 94:595-599.
6. Bates S.M., Greer I.A., Pabinger I., et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:844S-886S.
7. Ray J.G., Chan W.S. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999, 54:265-271.
8. Goldhaber S.Z., Savage D.D., Garrison R.J., et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983, 74:1023-1028.
9. Ehrenberg H.M., Dierker L., Milluzzi C., et al. Prevalence of maternal obesity in an urban center. Am J Obstet Gynecol 2002, 187:1189-1193.
10. Lu G.C., Rouse D.J., DuBard M., et al. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001, 185:845-849.
11. Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer, 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 2007, Confidential Enquiry into Maternal and Child Health, CEMACH, London.
12. Green Top Guideline No 37. Thrombosis and Embolism During Pregnancy the Puerperium, Reducing the Risk Royal College of Obstetricians and Gynaecologists, Accessed June 7, 2011. http://www.rcog.org.uk/womens-health/clinical-guidance/reducing-risk-of-thrombosis-greentop37a.
13. Modder J., Fitzsimons K.J. CMACE/RCOG Joint Guideline: Management of Women with Obesity in Pregnancy 2010, Centre for Maternal and Child Enquiries/Royal College of Obstetricians and Gynaecologists (CMACE/RCOG), London.
14. Larsen T.B., Sørensen H.T., Gislum M., et al. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: A population-based nested case-control study. Thromb Res 2007, 120:505-509.
15. James A.H., Jamison M.G., Brancazio L.R., et al. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality. Am J Obstet Gynecol 2006, 194:1311-1315.
16. Knight M. Antenatal pulmonary embolism: Risk factors, management and outcomes. Br J Obstet Gynaecol 2008, 115:453-461. UKOSS.
17. Robinson H.E., O'Connell C.M., Joseph K.S., et al. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol 2005, 106:1357-1364.
18. Simpson E.L., Lawrenson R.A., Nightingale A.L., et al. Venous thromboembolism in pregnancy and the puerperium: Incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol 2001, 108:56-60.
19. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Ante- and postnatal risk factors of venous thrombosis: A hospital-based case-control study. J Thromb Haemost 2008, 6:905-912.
20. Tjepkema M. Adult obesity in Canada: Measured height and weight, in Findings from the Canadian Community Health Survey-Adult Obesity in Canada Accessed June 7, 2011. http://www.statcan.gc.ca/pub/82-620-m/2005001/pdf/4224906-eng.pdf.
21. Sosa C., Althabe F., Belizán J., et al. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 2004, 1. CD003581.
22. Crowther C.A., Han S. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2010, 7. CD000110.
23. Meher S., Abalos E., Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev 2005, 4. CD003514.
24. Duhl A.J., Paidas M.J., Ural S.H., et al. Antithrombotic therapy and pregnancy: Consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007, 197. 457.e1-457.21.
25. Davies G.A., Maxwell C., McLeod L., et al. SOGC clinical practice guidelines: Obesity in pregnancy. J Obstet Gynaecol Can 2010, 110:167-173.
26. ACOG Committee Opinion No: 315, 2005. Obesity in pregnancy. Obstet Gynecol 2005, 106:671-675. American College of Obstetricians and Gynecologists.
27. Liu S., Liston R.M., Joseph K.S., et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ 2007, 176:455-460.
28. Macklon N.S., Greer I.A. Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience. Scott Med J 1996, 41:83-86.
29. Jacobsen A.F., Drolsum A., Klow N.E., et al. Deep vein thrombosis after elective cesarean section. Thromb Res 2004, 113:283-288.
30. Gates S., Brocklehurst P., Ayers S., et al. Thromboprophylaxis and pregnancy: Two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol 2004, 191:1296-1303.
31. Gates S., Brocklehurst P., Davis L.J. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2002, 2. CD001689.
32. Burrows R.F., Gan E.T., Gallus A.S., et al. A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: A pilot study. Br J Obstet Gynaecol 2001, 108:835-839.
33. Hill N.C.W., Hill J.G., Sargent J.M. Effect of low dose heparin on blood loss at cesarean section. BMJ 1988, 296:1505-1506.
34. Andersen A.S., Berthelsen J.G., Bergholt T. Venous thromboembolism in pregnancy: Prophylaxis and treatment with low molecular weight heparin. Acta Obstet Gynecol Scand 2010, 89:15-21.
35. Quinlan D.J., McQuillan A., Eikelboom J.W. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trials. Ann Intern Med 2004, 140:175-183.
36. Weitz J.I. Low-molecular-weight heparins. N Engl J Med 1997, 337:688-698.
37. Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005, 106:401-407.
38. Warkentin T.E., Greinacher A., Koster A., et al. Treatment and prevention of heparin-induced thrombocytopenia: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:340S-380S.
39. Pettilä V., Leinonen P., Markkola A., et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002, 87:182-186.
40. Kominiarek M.A., Angelopoulos S.M., Shapiro N.L., et al. Low-molecular-weight heparin in pregnancy: Peripartum bleeding complications. J Perinatol 2007, 27:329-334.
41. Maslovitz S., Many A., Landsberg J.A., et al. The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonat Med 2005, 17:39-43.
42. Maxwell G.L., Synan I., Dodge R., et al. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: A randomized trial. Obstet Gynecol 2001, 98:989-995.
43. Quiñones J.N., James D.N., Stamilio D.M., et al. Thromboprophylaxis after cesarean delivery: A decision analysis. Obstet Gynecol 2005, 106:733-740.
44. Lim W. Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 2010, 29:233-240.
45. Baglin T., Barrowcliffe T.W., Cohen A., et al. Guidelines on the use and monitoring of heparin. Br J Haematol 2006, 133:19-34.
46. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-A register-based case-control study. Am J Obstet Gynecol 2008, 198:233.e1-233.e7.
47. Hawkins T.L., Lange I.R., Gibson P.S. Compliance with a perinatal prophylaxis policy for prevention of venous thromboembolism after caesarean section. J Obstet Gynaecol Can 2008, 30:1110-1117.
48. Horlocker T.T., Wedel D.J., Rowlingson J.C., et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (third edition). Reg Anesth Pain Med 2010, 35:64-101.